Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226-Reference-Cited by-同舟云学术

Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226

Published:2016-04-08 Issue:6 Volume:81 Page:1134-1141
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Hertz Daniel L.¹,Barlow William E.²,Kidwell Kelley M.³,Albain Kathy S.⁴,Vandenberg Ted A.⁵,Dakhil Shaker R.⁶,Tirumali Nagendra R.⁷,Livingston Robert B.⁸,Gralow Julie⁹,Hayes Daniel F.¹⁰,Hortobagyi Gabriel N.¹¹,Mehta Rita S.¹²,Rae James M.¹⁰

Affiliation:

1. College of Pharmacy; University of Michigan; Ann Arbor MI USA

2. SWOG Statistical Center; Seattle WA USA

3. University of Michigan, School of Public Health; Ann Arbor MI USA

4. Loyola University Chicago Stritch School of Medicine; Maywood IL USA

5. London Health Sciences Center/National Cancer Institute of Canada Clinical, Trials Group; London ON Canada

6. Wichita NCORP; Wichita KS USA

7. Kaiser Permanente NCORP; Portland OR USA

8. Arizona Cancer Center; University of Arizona; Tucson AZ USA

9. Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, University of Washington; Seattle WA USA

10. Division of Hematology/Oncology; University of Michigan Comprehensive Cancer Center; Ann Arbor MI USA

11. University of Texas; M.D. Anderson Cancer Center; Houston TX USA

12. University of California Irvine Medical Center, Chao Family Comprehensive, Cancer Center; Orange CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12904/fullpdf

Reference29 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Dowsett;Lancet,2015

3. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer;Howell;Lancet,2005

4. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer;Mouridsen;N Engl J Med,2009

5. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer;Pagani;N Engl J Med,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226;Pharmacogenomics;2023-08

2. Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials;Breast Cancer Research and Treatment;2020-02-01

3. Fulvestrant in the treatment of hormone receptor‐positive/human epidermal growth factor receptor 2‐negative advanced breast cancer: A review;Cancer Medicine;2019-04-19

4. Fulvestrant for the treatment of advanced breast cancer;Expert Review of Anticancer Therapy;2018-05-15

5. An Environmentally Benign Synthesis of Pyrimidine-Fused Coumarin and Triazole Motifs via a Catalytic Domino Reaction;Organic Preparations and Procedures International;2017-11-02